Detection of Hpv Genotypes and Their Association With p53 Codon 72 Polymorphism in Prostate Cancer

References

• Ferlay J , ParkinD, Steliarova-FoucherE . Estimates of cancer incidence and mortality in Europe in 2008 . Eur. J. Cancer46 ( 4 ), 765 – 781 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhu Y , WangH-K, QuY-Y, YeD-W . Prostate cancer in east Asia: evolving trend over the last decade . Asian J. Androl.17 ( 1 ), 48 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pakzad R , RafiemaneshH, GhonchehMet al. Prostate cancer in Iran: trends in incidence and morphological and epidemiological characteristics . Asian Pac. J. Cancer Prev.17 ( 2 ), 839 – 843 ( 2016 ).
   PubMedGoogle Scholar
• Mousavi SM , GouyaMM, RamazaniRet al. Cancer incidence and mortality in Iran . Ann. Oncol.20 ( 3 ), 556 – 563 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lee CH , Akin-OlugbadeO, KirschenbaumA . Overview of prostate anatomy, histology, and pathology . Endocrinol. Metab. Clin. North Am.40 ( 3 ), 565 – 575 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hoffman RM . Screening for prostate cancer . N. Engl. J. Med.365 ( 21 ), 2013 – 2019 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nam R , ToiA, KlotzLet al. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer . Can. J. Urol.13, 2 – 10 ( 2006 ).
   PubMedGoogle Scholar
• Alibek K , KaratayevaN, BekniyazovI . The role of infectious agents in urogenital cancers . Infect. Agent. Cancer7 ( 1 ), 35 ( 2012 ).
   PubMedGoogle Scholar
• Korodi Z , DillnerJ, JellumEet al. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study . Cancer Epidemiol. Biomarkers Prev.14 ( 12 ), 2952 – 2955 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Martinez-Fierro ML , LeachRJ, Gomez-GuerraLSet al. Identification of viral infections in the prostate and evaluation of their association with cancer . BMC Cancer10 ( 1 ), 326 ( 2010 ).
   PubMedGoogle Scholar
• Lin Y , MaoQ, ZhengXet al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis . Ir. J. Med. Sci.180 ( 2 ), 497 – 503 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Silvestre RVD , LealMF, DemachkiSet al. Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil . Mem. Inst. Oswaldo Cruz104 ( 4 ), 665 – 667 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Derry WB , PutzkeAP, RothmanJH . Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance . Science294 ( 5542 ), 591 – 595 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Huang S-P , WuW-J, ChangW-SWet al. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer . Cancer Epidemiol. Biomarkers Prev.13 ( 12 ), 2217 – 2224 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Yu H , HuangYJ, LiuZet al. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck . Mol. Carcinog.50 ( 9 ), 697 – 706 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Leiros GJ , GallianoSR, SemberMEet al. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina . BMC Urol.5 ( 1 ), 15 ( 2005 ).
   PubMedGoogle Scholar
• Soulitzis N , SourvinosG, DokianakisDN, SpandidosDA . p53 codon 72 polymorphism and its association with bladder cancer . Cancer lett.179 ( 2 ), 175 – 183 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Zehbe I , VoglinoG, WilanderEet al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development . Cancer Res.61 ( 2 ), 608 – 611 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Henner W , EvansAJ, HoughKM, HarrisEL, LoweBA, BeerTM . Association of codon 72 polymorphism of p53 with lower prostate cancer risk . Prostate49 ( 4 ), 263 – 266 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Tabatabai SH , NabieyanM, SheikhhaMHet al. Detection of human papillomavirus 16 and 18 types in oral squamous cell carcinoma patients in Yazd, Iran: a case-control study . J. Paramed. Sci.6 ( 1 ), ( 2015 ).
   PubMedGoogle Scholar
• Remmerbach TW , BrinckmannUG, HemprichA, ChekolM, KuhndelK, LiebertUG . PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets . J. Clin. Virol.30 ( 4 ), 302 – 308 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• BioEdit . www.mbio.ncsu.edu/bioedit/bioedit.html .
   Google Scholar
• Babaei F , AhmadiSA, AbiriRet al. The TP53 codon 72 polymorphism and risk of sporadic prostate cancer among Iranian patients . Iran J. Public Health43 ( 4 ), 453 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• The National Center for Biotechnology Information . www.ncbi.nlm.nih.gov .
   Google Scholar
• MEGA (Molecular Evolutionary Genetics Analysis) . www.megasoftware.net .
   Google Scholar
• Aghakhani A , HamkarR, ParvinMet al. The role of human papillomavirus infection in prostate carcinoma . Scand. J. Infect. Dis.43 ( 1 ), 64 – 69 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chen AC-H , WaterboerT, KeleherAet al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients . Pathol. Oncol. Res.17 ( 3 ), 613 – 617 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Petersen I , KleinF . [HPV in non-gynecological tumors] . Pathologe29, 118 – 122 ( 2008 ).
   PubMedGoogle Scholar
• Gazzaz FS , MosliHA . Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies . Saudi Med. J.30 ( 5 ), 633 – 637 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Salmena L . PTEN: history of a tumor suppressor . Methods Mol. Biol.3 – 11 ( 2016 ).
   PubMedGoogle Scholar
• Hu S , ZhaoL, YangJ, HuM . The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases . Meta Gene1, 126 – 137 ( 2014 ).
   Google Scholar
• Salehi Z , HadaviM . Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer . J. Med. Virol.84 ( 9 ), 1423 – 1427 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang J , ZhuoW-L, ZhengY, ZhangY-S . Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis . Med. Oncol.27 ( 2 ), 540 – 546 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Das BC , HussainS, NasareV, BharadwajM . Prospects and prejudices of human papillomavirus vaccines in India . Vaccine26 ( 22 ), 2669 – 2679 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Adami H-O , KuperH, AnderssonS-O, BergströmR, DillnerJ . prostate cancer risk and serologic evidence of human papilloma virus infection a population-based case-control study . Cancer Epidemiol. Biomarkers Prev.12 ( 9 ), 872 – 875 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Carozzi F , LombardiF, ZendronPet al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies . The Int. J. Biol. Markers19 ( 4 ), 257 – 261 ( 2003 ).
   Web of Science ®Google Scholar
• Sun T , LeeG-SM, OhWKet al. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population . Clin. Cancer Res.16 ( 21 ), 5244 – 5251 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Dumont P , LeuJ-J, Della PietraAC, GeorgeDL, MurphyM . The codon 72 polymorphic variants of p53 have markedly different apoptotic potential . Nat. Genet.33 ( 3 ), 357 – 365 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Roberts CC , SwoyerR, BryanJT, TaddeoFJ . Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection . J. Clin. Microbiol.49 ( 5 ), 1899 – 1906 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Storey A , ThomasM, KalitaAet al. Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer . Nature393 ( 6682 ), 229 – 234 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Whibley C , PharoahPD, HollsteinM . p53 polymorphisms: cancer implications . Nat. Rev. Cancer9 ( 2 ), 95 – 107 ( 2009 ).
   PubMed Web of Science ®Google Scholar